Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

CIS001 Extension Study of Cyclosporine Inhalation Solution (CIS002)

This study has been terminated.
(Parent study CIS001 was completed)
Information provided by (Responsible Party):
APT Pharmaceuticals, Inc. Identifier:
First received: July 9, 2009
Last updated: September 13, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)